Skip to content

Clinical trials

Phase 2/3 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2/3 Clear all

119 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20023
20031
20041
20054
20065
20071
20083
20094
20104
20116
201211
20134
20148
20152
20164
20178
201810
20191
20205
20216
20227
20237
20243
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Unknown status33
Terminated14
Recruiting13
Active, not recruiting8
Withdrawn4
Not yet recruiting4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University4
Fudan University4
Peking Union Medical College Hospital4
The Netherlands Cancer Institute4
Tianjin Medical University4
Hebei Medical University Fourth Hospital3
M.D. Anderson Cancer Center3
Mansoura University3
Zhiyong Yu3
Danish Cancer Society2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms119
Lung Neoplasms4
Neoplasm Metastasis4
Neoplasms4
Triple Negative Breast Neoplasms4
Colorectal Neoplasms3
Fatigue3
Head and Neck Neoplasms3
Melanoma3
Prostatic Neoplasms3

Trials

Showing 26 to 50 of 119. Each trial links to its page on Pharma Observatory.

19 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.